is that really matter if you are holding for the mid-long term? fully diluted will change the company w/more $29m. so lets assume the worst case scenario of 32m shares (by year-end 2017),and about 37m cash. on good phase 2 results DCTH will skyrocket. Liver Cancer
Potential Market Size between $2-$8 Billion if succeeded, similar companies from bio. field on same stage have value $400MM
$DCTH Potential Market Size between $2-$8 Billion, similar companies from bio. field on same stage have value $400MM pic.twitter.com/VvWwuRSs8z